.05
[]. A H Vaidya, et al. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and -PP to anxiolytic action. Methods Find Exp Clin Pharmacol. 2005 May;27():25-55.
[2]. Donald M N Sikazwe, et al. Synthesis and evaluation of ligands for D2-like receptors: the role of common pharmacophoric groups. Bioorg Med Chem. 2009 Feb 5;7():76-23.
[3]. I Berlin, et al. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite -(2-pyrimidinyl)-piperazine. Br J Clin Pharmacol. 995 Mar;39(3):23-9.
[]. J Odontiadis, et al. Simultaneous quantitation of buspirone and its major metabolite -(2-pyrimidinyl)piperazine in human plasma by high-performance liquid chromatography with coulometric detection. J Pharm Biomed Anal. 996 Jan;(3):37-5.
[5]. Jinjun Wu, et al. The significant inhibition on CYP3A caused by radix Aconiti single herb is not observed in the Wutou decoction: The necessity of combination therapy of radix Aconiti. J Ethnopharmacol. 205 Jul 2:70:25-.
H302-H35-H39-H335
P26-P26-P270-P27-P280-P302+P352-P30+P30-P305+P35+P338-P330-P362+P36-P03+P233-P05-P50
![]()
![]()